{"organizations": ["American College of Gastroenterology Annual", "Morgan Stanley Global Healthcare Conference", "EU Pharmacovigilance Legislation Course", "Valeant Pharmaceuticals International, Inc.", "Elekta", "Morgan Stanley Global   Valeant Pharmaceuticals To Acquire Synergetics USA", "Host Cancer Survivorship Event at Company", "LINC", "Leksell Gamma Knife", "Cancer Institute"], "uuid": "25aec77affe4adb62793fdb5c5a5385ddc9e88c5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/New-EU-Pharmacovigilance-Legislation-Course---London--UK---November-16-17--2015-47944-1/", "country": "US", "title": "New EU Pharmacovigilance Legislation Course - London, UK - November 16-17, 2015", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "New EU Pharmacovigilance Legislation Course - London, UK - November 16-17, 2015", "spam_score": 0.0, "site_type": "news", "published": "2015-09-02T20:51:00.000+03:00", "replies_count": 0, "uuid": "25aec77affe4adb62793fdb5c5a5385ddc9e88c5"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/New-EU-Pharmacovigilance-Legislation-Course---London--UK---November-16-17--2015-47944-1/", "ord_in_thread": 0, "title": "New EU Pharmacovigilance Legislation Course - London, UK - November 16-17, 2015", "locations": ["Mass.", "Atlanta", "Boston", "UK", "London"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Dan", "Mike Mahoney", "Takeda"], "text": "  , September 2, 2015 Elekta, ... on cancer survivorship on September 10, 6:30-8:30 p.m., at Elekta,s ... Elekta,s Ultimate Ride to Survivorship \" will feature Professional BMX ... treatment of a brain tumor with Leksell Gamma KnifeÂ®, Elekta,s ... 48,070 new cancer cases will be diagnosed in   Mass. , Sept. 2, 2015 Boston Scientific ... the 2015 Morgan Stanley Global Healthcare Conference on September 17, ... Mike Mahoney , chief executive officer, and Dan ... participate in a 30-minute question and answer session regarding the ... ET. A live webcast of the question and   2015 Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... has entered into a definitive agreement under which Valeant ... (NASDAQ: SURG ) for $6.50 per share in ... stockholders will receive additional cash payments of up to ... following the closing. The transaction is expected to close ... [ 0 ] Elekta to Host Cancer Survivorship Event at Company's Learning and Innovation Center (LINC) in Atlanta [ 0 ] Boston Scientific To Participate In 2015 Morgan Stanley Global   Valeant Pharmaceuticals To Acquire Synergetics USA ... October 7 , - 125 Patient, Prospective ... Overall Survival, Bavarian Nordic has now evaluated ... cancer vaccine candidate PROSTVAC(TM) that had been,obtained as ... National,Cancer Institute (NCI) in the US., The ... ... Data Presented at the American College of Gastroenterology Annual ... ... Oct. 6 Combined results from two Phase 3,studies presented at ... demonstrated that TAK-390MR,resulted in higher healing rates than lansoprazole among patients ... Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed  ", "external_links": [], "published": "2015-09-02T20:51:00.000+03:00", "crawled": "2015-09-03T03:07:22.496+03:00", "highlightTitle": ""}